RISK

Orgenesis Announces Collaboration Agreement with Savicell to License and Deploy its ImmunoBiopsy™ Platform

Retrieved on: 
Monday, August 23, 2021
Well, Industry, ATP, Drug Quality and Security Act, Cancer, U.S. Securities and Exchange Commission, QC, Trial of the century, Infection, Immune system, Diagnosis, An Act to exempt a particular class of securities from the Securities and Exchange Act, Survival, GLOBE, Diabetes, Protest and strikes of the CGT union 2021, Liquid biopsy, Coronavirus, Research, RISK, Lung cancer, Agreement, Disease, Therapy, Cell, Hospital, Securities Act of 1933, NASDAQ, Oxidative phosphorylation, Cancer immunology, Patient, CEO, FDA, Quality control, JV, Annual report, Technology, Security (finance), CGT, Vaccine, Pharmaceutical industry, Medical imaging

GERMANTOWN, Md., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, has entered into a collaboration agreement (“Agreement”) with Savicell Diagnostics Ltd. (“Savicell”) to deploy Savicell’s patented ImmunoBiopsy™ immunometabolism platform with a goal of: (i) developing and validating diagnostic kits for enhanced quality control (QC) and monitoring purposes to be used by Orgenesis in manufacturing and processing of its cell and gene therapies; (ii) developing new assays to enhance the potency of cell and gene therapies for use within its point-of-care (POCare) platform; and (iii) developing companion diagnostics for potential enhanced patient targeting of cell and gene therapies.

Key Points: 
  • Specifically, T cells change their pathways to create metabolic energy (ATP molecules) to enable them to potentially kill cancer.
  • This shift into the glycolysis cycle enables faster production of energy for immediate utilization than in other cycles.
  • Vered Caplan, CEO of Orgenesis, stated, Savicells ImmunoBiopsy platform has shown promise in early detection of cancer.
  • We look forward to leveraging this technology in a number of key areas within our POCare platform.

The Knot Becomes Abercrombie’s “Plus One” With Launch of Co-Created “Best Dressed Guest” Collection

Retrieved on: 
Thursday, August 19, 2021
Company, Friends, Face, Private Securities Litigation Reform Act, Inclusivism, Twitter, Instagram, Love, GLOBE, Fierce, Collection, Leadership, Social media, RISK, Android, Knot, Abercrombie & Fitch Co. v. Hunting World, Inc., ANF, IOS, SVP, Pinterest, The Knot, NYSE, Abercrombie Kids, Marketing, Partnership, Abercrombie & Fitch, COVID-19, Fashion

Combining Abercrombies reputation as a retailer of high-quality apparel and accessories with The Knots leadership in weddings and events has manifested in a versatile, fashion-forward and inclusive collection.

Key Points: 
  • Combining Abercrombies reputation as a retailer of high-quality apparel and accessories with The Knots leadership in weddings and events has manifested in a versatile, fashion-forward and inclusive collection.
  • The collection features falls top trending colors and styles, including chic neutrals, sunset colors and wedding-worthy patterns, as well as minimalist silhouettes.
  • To shop the Abercrombie x The Knot Best Dressed Guest collection, visit abercrombie.com or learn more at https://www.theknot.com/content/the-knot-abercrombie-guest-attire-collec... .
  • Visit The Knot online at TheKnot.com and follow on social media: Facebook.com/TheKnot and @TheKnot on Twitter, Pinterest and Instagram.

Upsher-Smith Launches Carbamazepine Extended-Release Tablets, USP

Retrieved on: 
Monday, August 16, 2021
CONTROL, Multimedia, THE, Novartis, DRUG, STEVENS-JOHNSON SYNDROME, DATA, USP, VAST, Carbamazepine, RISK, FATAL, AN, LLC, CELL, FDA, SJS, Health, View, Patient, Development, MORE, TEN, NEW, TIMES, Upsher-Smith Laboratories, Industry, Pharmaceutical industry

PATIENTS WITH ANCESTRY IN GENETICALLY AT-RISK POPULATIONS SHOULD BE SCREENED FOR THE PRESENCE OF HLA-B*1502 PRIOR TO INITIATING TREATMENT WITH CARBAMAZEPINE.

Key Points: 
  • PATIENTS WITH ANCESTRY IN GENETICALLY AT-RISK POPULATIONS SHOULD BE SCREENED FOR THE PRESENCE OF HLA-B*1502 PRIOR TO INITIATING TREATMENT WITH CARBAMAZEPINE.
  • PATIENTS TESTING POSITIVE FOR THE ALLELE SHOULD NOT BE TREATED WITH CARBAMAZEPINE UNLESS THE BENEFIT CLEARLY OUTWEIGHS THE RISK[SEE WARNINGS AND PRECAUTIONS, LABORATORY TESTS ].
  • APLASTIC ANEMIA AND AGRANULOCYTOSIS HAVE BEEN REPORTED IN ASSOCIATION WITH THE USE OF CARBAMAZEPINE.
  • Please refer to the full Prescribing Information, including Boxed Warning for Carbamazepine Extended-Release Tablets, USP here .

Labcorp Extends Leadership in Women’s Health With Acquisition of Ovia Health

Retrieved on: 
Thursday, August 12, 2021
Medical Devices, Women, Practice Management, Biotechnology, Other Health, Health, Consumer, Pharmaceutical, General Health, Method, Multimedia, Parenting, LH, Clinical trial, NYSE, Drug development, LinkedIn, University, Science, RISK, COVID-19, Reproductive health, SEC, Research, Failure, Acquisition, Local government, Public opinion, Annual report, Ovia, Health, Patient, Leadership, Pregnancy, Kilpatrick Townsend & Stockton, Information technology, Genetics, Woman, Health care reform, Review, Hospital, Pharmaceutical industry, Medicine

Were excited to expand our leadership in womens health solutions by bringing Ovia Healths trusted health content and easy-to-use digital platforms to our patients and customers.

Key Points: 
  • Were excited to expand our leadership in womens health solutions by bringing Ovia Healths trusted health content and easy-to-use digital platforms to our patients and customers.
  • We welcome Ovia Healths innovative and dedicated team to Labcorp and look forward to bringing the combination of our strengths in womens health to our customers.
  • Labcorp, through its wide-ranging specialty testing services and deep diagnostics and genetics expertise, is a leader in womens health.
  • Additionally, Ovia Health furnishes numerous employers and health plans with valuable clinical, health and wellness programs to enhance their existing offerings.

Ucommune International Ltd. (NASDAQ: UK) Strong REIT Asset Management Capability Central to Future Growth

Retrieved on: 
Thursday, August 12, 2021
Income, Stone Street, Tier 1 capital, Research report, Environment, Company, Risk, Real estate investment trust, Broker-dealer, RISK, NOT, REIT, SEC, Research, The Company, CBRE, ROI, AC, Exercise, Regulation, City, Stone Street (Manhattan), Property management, Real estate, Security (finance)

Overall, occupancy rates for most of the Company's projects ranged between 80%-95% according to the Company's press release.

Key Points: 
  • Overall, occupancy rates for most of the Company's projects ranged between 80%-95% according to the Company's press release.
  • Empowered by its comprehensive services and superior project and asset management skills, UK can bring compelling value proposition to landlords and partners, meanwhile laying the foundation for future development of its own REIT business down the road.
  • With Ucommune's strong asset management capabilities, the issuance of REITs is evidently becoming central to the Company's growth strategy going forward.
  • Built on top of its proven asset management capability, Ucommune is committed to creating an integrated asset management business spanning the value chain including investment origination, project financing, property management, and exits.

abercrombie kids Renews “Kind Crew” Digital Series for Second Season

Retrieved on: 
Thursday, August 12, 2021
Abercrombie Kids, Nickelodeon, Velocity, Anxiety, Abercrombie & Fitch, NYSE, Abercrombie, Company, Marketing, YouTube, Private Securities Litigation Reform Act, RISK, COVID-19, Partnership, GLOBE, Instagram, SVP, Abercrombie & Fitch Co. v. Hunting World, Inc., Social media, ANF, Racism, Life, Fashion

NEW ALBANY, Ohio, Aug. 12, 2021 (GLOBE NEWSWIRE) -- abercrombie kids, a brand in the Abercrombie & Fitch Co. (NYSE: ANF) portfolio, has renewed its popular Kind Crew digital series for a second season, which is available now exclusively on Nickelodeons YouTube channel.

Key Points: 
  • NEW ALBANY, Ohio, Aug. 12, 2021 (GLOBE NEWSWIRE) -- abercrombie kids, a brand in the Abercrombie & Fitch Co. (NYSE: ANF) portfolio, has renewed its popular Kind Crew digital series for a second season, which is available now exclusively on Nickelodeons YouTube channel.
  • Were so proud to bring the Kind Crew back for a second season, and to continue to provide a space for kids and their families to discuss topics that impact kids daily lives, said Carey Krug, SVP of Marketing at Abercrombie & Fitch.
  • We hope the second season of the Kind Crew inspires kids to both share their feelings and support one another as we head back to school this year.
  • In addition to appearing on the YouTube series, throughout the season, the new Kind Crew cast will engage with fellow kids via social media posts on their own channels and the abercrombie kids brand accounts.

NinjaTrader Announces FCM to Support Retail Futures Traders

Retrieved on: 
Monday, August 9, 2021
Software, Technology, Professional Services, Finance, Software, RISK, Industry, LLC, CEO, FCM, Commodity broker, Financial services, Retail

As a non-clearing Futures Commission Merchant, NinjaTrader Clearing will deliver innovative Fintech services & a modern user experience for self-directed traders to cost-effectively access the global futures markets.

Key Points: 
  • As a non-clearing Futures Commission Merchant, NinjaTrader Clearing will deliver innovative Fintech services & a modern user experience for self-directed traders to cost-effectively access the global futures markets.
  • We are extremely excited to introduce a customer-centric experience unique to the futures industry through our FCM, stated Martin Franchi, CEO of NinjaTrader.
  • The interest in retail futures trading is rapidly expanding and the opportunity to simplify the client experience will help us continue to deliver unmatched value for our traders.
  • NinjaTrader supports over 500,000 active traders through a unique combination of high-performance trading software, discount futures brokerage and real-time support.